Anchorage Capital Group, L.L.C. Ginkgo Bioworks Holdings, Inc. Transaction History
Anchorage Capital Group, L.L.C.
- $316 Million
- Q2 2024
A detailed history of Anchorage Capital Group, L.L.C. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 69,854,593 shares of DNA stock, worth $585 Million. This represents 7.28% of its overall portfolio holdings.
Number of Shares
69,854,593
Previous 69,854,593
-0.0%
Holding current value
$585 Million
Previous $81 Million
71.55%
% of portfolio
7.28%
Previous 21.46%
Shares
3 transactions
Others Institutions Holding DNA
# of Institutions
220Shares Held
718MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$263 Million0.02% of portfolio
-
Legal & General Group PLC London, X027MShares$226 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...